Efflux ratio cannot assess P-glycoprotein-mediated attenuation of absorptive transport: asymmetric effect of P-glycoprotein on absorptive and secretory transport across Caco-2 cell monolayers
- PMID: 12948018
- DOI: 10.1023/a:1025049014674
Efflux ratio cannot assess P-glycoprotein-mediated attenuation of absorptive transport: asymmetric effect of P-glycoprotein on absorptive and secretory transport across Caco-2 cell monolayers
Abstract
Purpose: The purpose of this work was to determine whether P-glycoprotein (P-gp) modulates absorptive and secretory transport equally across polarized epithelium (i.e., Caco-2 cell monolayers) for structurally diverse P-gp substrates, a requirement for the use of the efflux ratio to quantify P-gp-mediated attenuation of absorption across intestinal epithelium.
Methods: Studies were performed in Caco-2 cell monolayers. Apparent permeability (P(app)) in absorptive (P(app,AB)) and secretory (P(app,BA)) directions as well as efflux ratios (P(app,BA)/P(app,AB)) were determined for substrates as a function of concentration. Transport of these compounds (10 microM) was measured under normal conditions and in the presence of the P-gp inhibitor, GW918 (1 microM), to dissect the effect of P-gp on absorptive and secretory transport. Apparent biochemical constants of P-gp-mediated efflux activity were calculated for both transport directions.
Results: Efflux ratios for rhodamine 123 and digoxin were comparable (approx. 10). However, transport studies in the presence of GW918 revealed that P-gp attenuated absorptive transport of digoxin by approx. 8-fold but had no effect on absorptive transport of rhodamine 123 (presumably because absorptive transport of rhodamine 123 occurs via paracellular route). The apparent Km for P-gp-mediated efflux of digoxin was > 6-fold larger in absorptive vs. secretory direction. For structurally diverse P-gp substrates (acebutolol, colchicine, digoxin, etoposide, methylprednisolone, prednisolone, quinidine, and talinolol) apparent Km was approximately 3 to 8-fold greater in absorptive vs. secretory transport direction, whereas apparent J(max) was somewhat similar in both transport directions.
Conclusions: P-gp-mediated efflux activity observed during absorptive and secretory transport was asymmetric for all substrates tested. For substrates that crossed polarized epithelium via transcellular pathway in both directions, this difference appears to be caused by greater apparent Km of P-gp-mediated efflux activity in absorptive vs. secretory direction. These results clearly suggest that use of efflux ratios could be misleading in predicting the extent to which P-gp attenuates the absorptive transport of substrates.
Similar articles
-
Rhodamine 123 requires carrier-mediated influx for its activity as a P-glycoprotein substrate in Caco-2 cells.Pharm Res. 2003 Aug;20(8):1192-9. doi: 10.1023/a:1025096930604. Pharm Res. 2003. PMID: 12948017
-
Novel experimental parameters to quantify the modulation of absorptive and secretory transport of compounds by P-glycoprotein in cell culture models of intestinal epithelium.Pharm Res. 2003 Aug;20(8):1210-24. doi: 10.1023/a:1025001131513. Pharm Res. 2003. PMID: 12948019
-
Potential P-glycoprotein-mediated herb-drug interaction of phyllanthin at the intestinal absorptive barrier.J Pharm Pharmacol. 2019 Feb;71(2):213-219. doi: 10.1111/jphp.13019. Epub 2018 Sep 25. J Pharm Pharmacol. 2019. PMID: 30251430
-
Mechanistic analysis for drug permeation through intestinal membrane.Drug Metab Pharmacokinet. 2007 Apr;22(2):67-77. doi: 10.2133/dmpk.22.67. Drug Metab Pharmacokinet. 2007. PMID: 17495413 Review.
-
Mechanistic kinetic modeling generates system-independent P-glycoprotein mediated transport elementary rate constants for inhibition and, in combination with 3D SIM microscopy, elucidates the importance of microvilli morphology on P-glycoprotein mediated efflux activity.Expert Opin Drug Metab Toxicol. 2018 Jun;14(6):571-584. doi: 10.1080/17425255.2018.1480720. Epub 2018 Jun 7. Expert Opin Drug Metab Toxicol. 2018. PMID: 29788828 Review.
Cited by
-
Potential drug-drug interaction of olverembatinib (HQP1351) using physiologically based pharmacokinetic models.Front Pharmacol. 2022 Dec 13;13:1065130. doi: 10.3389/fphar.2022.1065130. eCollection 2022. Front Pharmacol. 2022. PMID: 36582520 Free PMC article.
-
A novel screening strategy to identify ABCB1 substrates and inhibitors.Naunyn Schmiedebergs Arch Pharmacol. 2009 Jan;379(1):11-26. doi: 10.1007/s00210-008-0345-0. Epub 2008 Aug 29. Naunyn Schmiedebergs Arch Pharmacol. 2009. PMID: 18758752
-
Saturable absorptive transport of the hydrophilic organic cation ranitidine in Caco-2 cells: role of pH-dependent organic cation uptake system and P-glycoprotein.Pharm Res. 2006 Jun;23(6):1165-77. doi: 10.1007/s11095-006-0251-4. Epub 2006 Jun 8. Pharm Res. 2006. PMID: 16741655
-
Physiologically Based Pharmacokinetic Models for Adults and Children Reveal a Role of Intracellular Tubulin Binding in Vincristine Disposition.CPT Pharmacometrics Syst Pharmacol. 2019 Oct;8(10):759-768. doi: 10.1002/psp4.12453. Epub 2019 Aug 30. CPT Pharmacometrics Syst Pharmacol. 2019. PMID: 31420944 Free PMC article.
-
Preclinical disposition (in vitro) of novel μ-opioid receptor selective antagonists.Drug Metab Dispos. 2011 Sep;39(9):1589-96. doi: 10.1124/dmd.111.038588. Epub 2011 Jun 17. Drug Metab Dispos. 2011. PMID: 21685245 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous